Injection suspension
Diphtheria vaccine, adsorbed
Not less than 30 IU of diphtheria toxoid/0.5 ml;
20-dose vaccine
Primary vaccination
Booster vaccination
An appropriate level of immunity against diphtheria is achieved after using all doses of diphtheria vaccination in accordance with the National Vaccination Program, which contains information about these vaccinations.
The immunizing properties of the vaccine are enhanced by the action of aluminum hydroxide (adjuvant).
The vaccine meets the requirements of the European Pharmacopoeia and the World Health Organization.
rash, shortness of breath, swelling of the face and tongue,
If there are any contraindications to vaccination with D - Diphtheria vaccine adsorbed, the doctor should assess the risk of administering the vaccine in relation to the risk of infection.
Before starting to use D - Diphtheria vaccine adsorbed, discuss it with your doctor or nurse if any side effects or other worrying reactions occurred after the previous dose of the vaccine.
Vaccination should be preceded by a medical examination and interview about the child's general health and previously performed and recorded vaccinations. This procedure allows for predicting the risk of side effects after administering the vaccine.
The vaccine contains thiomersal as a preservative, so allergic reactions may occur in the vaccinated child. Inform your doctor if you have had or have known allergic reactions. You should also inform your doctor if you have had health disorders after previous vaccination.
Tell your doctor about all medicines your child is taking or has recently taken, as well as any medicines your child will be taking.
Not applicable. The vaccine is used only in children.
Not applicable. The vaccine is used only in children.
The vaccine will be administered by a doctor or nurse as a deep subcutaneous injection.
The recommended injection site is the deltoid muscle or the anterolateral part of the thigh.
The vaccine must never be administered intravascularly.
Primary vaccination
Primary vaccination consists of three doses of the vaccine:
Dose I
Dose II
Dose III
Children under 2 years
0.5 ml
0.5 ml
0.3 ml
Children aged
Booster vaccination
One dose of the vaccine 0.2 ml:
The dosing schedule is determined by the doctor after a thorough analysis of the primary and booster vaccination course against diphtheria.
There are no data on overdose.
In case of any further doubts related to the use of this vaccine, consult a doctor, pharmacist, or nurse.
Like any vaccine, this vaccine can cause side effects, although not everybody gets them.
In preterm infants (born at 28 weeks of gestation or earlier), within 2-3 days after vaccination, longer pauses between breaths may occur.
If you experience any side effects, including any side effects not listed in the leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website:
https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will allow for more information to be collected on the safety of the vaccine.
Store in a refrigerator (2°C - 8°C).
Do not freeze; in case of freezing, the vaccine should be destroyed.
The vaccine should be stored out of sight and reach of children.
Do not use this vaccine after the expiry date stated on the carton.
The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste containers. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of the vaccine is:
Diphtheria toxoid
not less than 30 IU
adsorbed on aluminum hydroxide, hydrated
not more than 0.7 mg Al
The other ingredients of the vaccine are: thiomersal, sodium chloride, and water for injections.
The vaccine is a white or almost white, homogeneous suspension in glass vials. During storage, a white sediment forms at the bottom of the vial, and a clear supernatant (liquid) forms above it.
The package contains 1 vial (10 ml)
Biomed S.A.
Al. Sosnowa 8
30-224 Krakow
Tel.: +48 12 37 69 200
Fax: +48 12 37 69 205
e-mail: informacjanaukowa@biomed.pl
-------------------------------------------------------------------------------------------------
Before use, shake the vial to obtain a homogeneous suspension.
Visually inspect the vaccine for any foreign particles or changes in appearance. If any changes are observed, do not use the vaccine.
The vaccine should be used within 24 hours after opening the vial.
Administer the vaccine dose deep subcutaneously.
Do not exceed a dose of 0.5 ml.
The recommended injection site is the deltoid muscle or the anterolateral part of the thigh.
Do not administer intravascularly! Ensure that the needle is not inserted into a blood vessel.
Note: due to the risk of anaphylactic shock associated with vaccine administration, the vaccination office should be equipped with a standard anaphylaxis kit.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.